Header Forschung

Clinical Translation

Swift translation of innovative high-throughput diagnostics into clinical practice

An important strategic aim of the NCT in Dresden and Heidelberg is the development of novel concepts for the systematic translation of molecular information into clinical action. The newly established NCT PMO (Precision Medicine in Oncology) Program provides a direct path from latest-generation molecular diagnostics within NCT MASTER to prospective, controlled clinical trials that will assess the efficacy of biology-guided cancer therapies and give patients access to targeted drugs that are otherwise not or only rarely available.

>> Overview of available trials in Dresden

>> Overview of available trials in Heidelberg

>> Overview of available trials of DKTK